Skip to main content
Compound
Codex
Ledger
Hubs
Tools
Guides
Bloodwork
Forum
Browse
Ledger
All hubs
GLP-1 & weight loss
SARMs
Steroids & PEDs
GH secretagogues
Healing peptides
Melanocortins
Nootropic peptides
SERMs
Aromatase inhibitors
Cosmetic peptides
Mitochondrial peptides
Women
Compare
Watchlist
Topics
Reference
Guides
The toolkit
How we grade · the Codex Scale
Changelog
Testing labs
Citations
Calculator & converter
Bloodwork analysis
Marker reference
Resources
Community
Forum
Site
Home
About
Editorial process
Standards
Contact
Search
RSS
Independent reference & toolkit
100
compounds graded · Last reviewed June 2026
topics
/ mash
Tagged mash.
7/10 · Moderate
Survodutide: Strong Phase 2 data and a first Phase 3 readout, but still investigational
An investigational GLP-1/glucagon dual agonist with solid placebo-controlled Phase 2 trials and one positive Phase 3 topline, but no approval and no peer-reviewed Phase 3 data.